1. Home
  2. SMID vs TLSA Comparison

SMID vs TLSA Comparison

Compare SMID & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

HOLD

Current Price

$30.94

Market Cap

157.6M

Sector

Industrials

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$0.91

Market Cap

155.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMID
TLSA
Founded
1960
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.6M
155.3M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
SMID
TLSA
Price
$30.94
$0.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.6K
266.6K
Earning Date
04-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
62.76
N/A
EPS
0.25
N/A
Revenue
$93,446,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$121.12
N/A
Revenue Growth
19.03
N/A
52 Week Low
$25.60
$0.87
52 Week High
$43.62
$2.60

Technical Indicators

Market Signals
Indicator
SMID
TLSA
Relative Strength Index (RSI) 56.37 36.84
Support Level $28.01 N/A
Resistance Level $31.21 $1.45
Average True Range (ATR) 1.11 0.12
MACD 0.19 -0.03
Stochastic Oscillator 69.13 10.55

Price Performance

Historical Comparison
SMID
TLSA

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: